Resonance Health Limited (ASX:RHT)

Resonance Health Ratios and Metrics

Market cap in millions AUD. Fiscal year is July - June.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jan 21, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Market Capitalization	21	18	26	19	26	71
Market Cap Growth	-17.99%	-32.02%	36.13%	-25.00%	-63.87%	7.38%
Enterprise Value	22	18	21	13	18	63
Last Close Price	0.04	0.04	0.06	0.04	0.06	0.15
PE Ratio	-	-	155.74	-	-	122.01
PS Ratio	1.89	1.62	3.07	4.40	6.70	18.92
PB Ratio	2.22	1.91	2.41	1.95	2.42	6.04
P/TBV Ratio	8.70	7.47	7.18	1.95	2.42	6.04
P/FCF Ratio	25.94	22.26	22.77	-	-	63.34
P/OCF Ratio	16.73	14.36	19.01	-	-	60.96
EV/Sales Ratio	1.96	1.63	2.42	2.99	4.75	16.79
EV/EBITDA Ratio	-	-	-	-	-	151.50
EV/EBIT Ratio	-	-	-	-	-	158.72
EV/FCF Ratio	26.96	22.36	17.95	-	-	56.23
Debt / Equity Ratio	0.41	0.41	0.34	0.03	0.03	0.01
Debt / EBITDA Ratio	-	-	-	-	-	0.13
Debt / FCF Ratio	4.72	4.72	3.19	-	-	0.05
Asset Turnover	0.58	0.58	0.55	0.39	0.32	0.33
Quick Ratio	1.25	1.25	1.49	8.57	9.76	15.77
Current Ratio	1.28	1.28	1.51	8.63	10.34	15.84
Return on Equity (ROE)	-17.05%	-17.05%	1.62%	-7.57%	-10.14%	5.39%
Return on Assets (ROA)	-5.18%	-5.18%	-2.11%	-7.50%	-7.90%	2.18%
Return on Invested Capital (ROIC)	-7.11%	-7.11%	-2.66%	-8.03%	-8.34%	2.28%
Return on Capital Employed (ROCE)	-12.50%	-12.50%	-3.70%	-13.50%	-14.00%	3.40%
Earnings Yield	-8.30%	-9.67%	0.64%	-4.03%	-4.42%	0.82%
FCF Yield	3.86%	4.49%	4.39%	-2.30%	-6.10%	1.58%
Buyback Yield / Dilution	2.81%	2.81%	-1.59%	-	-1.97%	-4.59%

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.